¶ … thirds of the global population lives within the Asia Pacific area where pervasiveness of diabetes has reached rampant proportion. With India and China being the most densely inhabited countries in the world, it is thought that over one hundred and fifty million diabetes cases reside in the area with more than a staggering 95% being of T2DM or type 2 diabetes mellitus. Additionally, other Pacific islands within the area have high rates of T2DM. These islands include Tonga, Nauru, French Polynesia, and Fiji. The latter possesses the highest occurrence of T2DM per populace in the globe. Over the past twenty, New Zealand and Australia, the incidence of T2DM has actually doubled, largely midst the Torres Strait Islander and Aboriginal and Maori peoples correspondingly. With the snowballing frequency of diabetes within the Asia Pacific area coupled with the inadequate number of resources, use of a consistent and efficient mode of diagnosis for type 2 diabetes mellitus is necessary. Yet to date, only nations like New Zealand have adopted the American Diabetes Association (ADA) recommendation of using test that include hemoglobin A1C in the initial diagnosis of the illness. The objective of the article is to discuss clinical practicality of hemoglobin A1C as well as highlight its diagnostic part in the Asia Pacific area where T2DM is progressively encountered.

Body

The introduction covers the prevalence of diabetes mellitus in the Asia Pacific region. This...

Many of those afflicted with diabetes mellitus that are diagnosed in later experience increased premature death. The A1C test may help introduce earlier diagnosis among the Asian Pacific population.
The newfound use of A1C as a diagnostic tool has been accepted internationally with the World Health Organization as well as the International Diabetes Federation recommending the use of A1C test to perform early diagnosis of the disease. The problem lies in the Asian Pacific regions late acceptance of this new standard. The A1C test is officially called the HbA1C and was previously used to help monitor a patient's glycemic control as well as guide therapy in people already diagnosed.

The test presents a great way to monitor and diagnose diabetes mellitus because it can be performed with or without consumption of food. It also does not require measuring blood glucose levels and provides an easy and inexpensive way to determine potential diabetes condition without too much energy spent on testing and getting results. Overall the articles highlights the effectiveness of this kind of test as well as the need for it in the Asian Pacific region as increased cases of late-onset diagnosed diabetes mellitus leads to costly treatments and medications.

The article continues with hemoglobin A1C in clinical…